Patheon Seeks to Import DMT and Magic Mushroom Drugs
Published Date: 3/19/2026
Notice
Summary
Patheon API Services, Inc. wants to become an official importer of certain controlled substances like dimethyltryptamine and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by April 20, 2026. This move could impact companies handling these substances and might affect how these drugs enter the U.S. market.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 1 costs, 1 mixed.
Import Limited to R&D Reference Standards
The company plans to import the listed substances only as reference standards for research and development as part of API Manufacturing, and "no other activities for these drug codes are authorized for this registration." The registration explicitly will not authorize import of FDA-approved or non‑approved finished dosage forms for commercial sale.
Company Applies to Import Specific Controlled Drugs
On February 19, 2026, Patheon API Services, Inc. applied to be registered to import these controlled substances: dimethyltryptamine (code 7435, Schedule I), psilocybin (7437, Schedule I), psilocyn (7438, Schedule I), amphetamine (1100, Schedule II), and methadone (9250, Schedule II). The notice is a public announcement of that application in the Federal Register.
Comment and Hearing Deadline: April 20, 2026
Registered bulk manufacturers of the affected basic classes, and applicants, may submit electronic comments or objections and may file a written request for a hearing on or before April 20, 2026. Comments must be submitted through https://www.regulations.gov; hearing requests have specified mailing addresses in Springfield, Virginia.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06523 — Designation of P2P Methyl Glycidic Acid as a List I Chemical
Starting May 4, 2026, anyone handling P2P methyl glycidic acid—a key chemical used to make illegal drugs like methamphetamine—must follow new government rules and register with the DEA. This means all transactions, big or small, will be closely watched to stop illegal drug production. Businesses dealing with this chemical should act fast to stay legal and avoid penalties.
2026-06521 — Importer of Controlled Substances Application: Lipomed/LGC Standards
Lipomed/LGC Standards wants to become an official importer of certain controlled substances, like 3-Fluoro-N-methylcathinone. This means companies involved with these drugs can comment or ask for a hearing by May 4, 2026. If approved, it could impact how these substances enter the U.S., but no direct costs are mentioned yet.
2026-06051 — Importer of Controlled Substances Application: Usona Institute
Usona Institute wants to become an official importer of some powerful controlled substances like mescaline and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by April 29, 2026. This move could impact research and medical use, with no direct cost changes announced yet.
2026-05912 — Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
SpecGx LLC wants to become a big-time maker of some powerful and tightly controlled drugs, including things like psilocybin and fentanyl. People and companies already registered can share their thoughts or ask for a hearing by May 26, 2026. This move could shake up how these substances are made and handled, so keep an eye on the deadlines if you’re involved!
2026-05618 — Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
Starting April 22, 2026, the DEA is putting 3-methoxyphencyclidine (3-MeO-PCP) into Schedule I, meaning it’s now officially a highly controlled substance with strict rules. This affects anyone who makes, sells, studies, or even possesses 3-MeO-PCP, who will face serious legal consequences. This move helps the U.S. follow international drug laws and keeps communities safer.
2026-05486 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) just updated which chemical mixes are officially exempt from strict drug rules between September 2024 and December 2025. Companies and labs using these chemicals should check the new list to see if their products are approved or denied. You’ve got until May 19, 2026, to share your thoughts, and no extra fees are involved—just a quick review and comment if you want!
Previous / Next Documents
Previous: 2026-05354 — Agency Information Collection Activities; Land Use Application and Permit
The Bureau of Land Management wants to keep collecting info for land use applications and permits, making sure the process stays smooth and paperwork light. If you apply for land use permits, this affects you! They’re asking for your thoughts by May 18, 2026, to help keep things clear and easy without extra costs or hassle.
Next: 2026-05356 — Importer of Controlled Substances Application: Siegfried Grafton, Inc.
Siegfried Grafton, Inc. wants to become an official importer of certain controlled substances, including Gamma Hydroxybutyric Acid and Marijuana Extract. People and companies involved with these drugs can share their thoughts or ask for a hearing by April 20, 2026. This move could impact how these substances enter the U.S. and might affect businesses handling them.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in